Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-124085
Filing Date
2024-11-08
Accepted
2024-11-08 16:10:06
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3646
  Complete submission text file 0000950170-24-124085.txt   5086
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Ciaramella Giuseppe (Reporting) CIK: 0001786322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39208 | Film No.: 241440637